The IndyCar Series is racing for the third straight weekend, this time at new street course around AT&T Stadium: Qualifying, race start time, how to watch.

Oracle (NYSE:ORCL) executives said fiscal third-quarter 2026 results exceeded expectations “across the board,” pointing to ...

Jai Opetaia won’t be defending the IBF cruiserweight title, but the Zuffa cruiserweight title is on the line tonight when the world’s top cruiserweight returns to face Brandon Glanton.

Shohei Ohtani and Japan knocked off Korea 8-6 today in pool play of the 2026 World Baseball Classic. Ohtani homered for the second straight game as the Japan team hit four home runs, including two by ...

Students said the idea for the project started about two years ago. BBC hits back in Trump's $10 billion lawsuit US judge throws out immigration board's ruling endorsing Trump mass detention policy ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

In case you've faced some hurdles solving the clue, Software program run through a browser, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

Feb. 4 (UPI) --Petróleos Mexicanos, Mexico's state-owned oil company known as Pemex, announced Wednesday a $24.7 billion investment program to increase and sustain crude oil production under a plan ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.